Immutep ADR Soars 1573% as EPS Growth Estimate Hits 25.5%
Immutep Limited ADR (IMMP) rocketed 1573.1% to $4.35 after its next-year EPS growth estimate was revised to 25.5%, leading a broad healthcare and tech rally. Lumentum (LITE) gained 17.8% to $1,085.42 and Coherent (COHR) rose 17.1% to $337.04, both driven by strong EPS growth projections of 57.6% and 49.9%, respectively. The moves suggest investors are aggressively pricing in future earnings acceleration across biotech and photonics.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| IMMP | Healthcare | 2026-09-27 | N/A | +1573.1% |
| PXS | Energy | 2026-09-29 | N/A | +20.0% |
| LITE | Technology | 2026-09-28 | N/A | +17.8% |
| COHR | Technology | 2026-09-30 | N/A | +17.1% |
| CAMT | Technology | 2026-09-28 | N/A | +15.8% |
Why did IMMP stock jump in October 2026?
Immutep ADR (IMMP) exploded 1573.1% from $0.26 to $4.35 after its next-year EPS growth estimate was revised to 25.5% on September 27, 2026.
The screener detected the upward revision early, and the stock's massive re-rating reflects heightened expectations for the clinical-stage biotech's earnings trajectory. With no company-specific news in the window, the move likely stemmed from sector-wide optimism around immuno-oncology and a low-float dynamic that amplified buying pressure. Investors appear to be positioning ahead of potential pipeline catalysts.
IMMP EPS revision history → · Screener snapshot from 2026-09-27 →
FAQ: IMMP
Why did IMMP stock jump?
IMMP stock jumped 1573.1% to $4.35 after its next-year EPS growth estimate was revised upward to 25.5% on September 27, 2026.
Is IMMP a buy after the rally?
IMMP's 25.5% EPS growth estimate supports a bullish case, but the 1573% surge in days suggests extreme volatility and risk; investors should weigh pipeline catalysts against valuation.
What is IMMP's EPS growth estimate?
Immutep's next-year EPS growth estimate stands at 25.5% as of the latest revision.
Why did PXS stock jump in October 2026?
Pyxis Tankers (PXS) climbed 20.0% from $6.44 to $7.73 after its next-year EPS growth estimate was revised to 39.0% on September 29, 2026.
The small-cap energy shipping firm benefited from the screener's early detection, which coincided with rising tanker rates and broader sector momentum. With no earnings-related news in the window, the rally likely reflects improving freight fundamentals and expectations of stronger cash flows. The sharp upward revision in EPS growth underscores a positive shift in analysts' outlook for the maritime transport space.
PXS EPS revision history → · Screener snapshot from 2026-09-29 →
FAQ: PXS
Why did PXS stock surge?
PXS surged 20% to $7.73 after its next-year EPS growth estimate was revised to 39.0% on September 29, 2026, driven by improving tanker market conditions.
Is PXS a buy after the rally?
With a 39% EPS growth estimate and rising tanker rates, PXS may appeal to value investors, but the 20% gain in four days suggests near-term consolidation risk.
What caused PXS's 20% gain?
The gain was triggered by a sharp upward revision in Pyxis Tankers' next-year EPS growth estimate to 39%, reflecting stronger shipping fundamentals.
Why did LITE stock jump in October 2026?
Lumentum Holdings (LITE) rose 17.8% from $921.32 to $1,085.42 after its next-year EPS growth estimate was revised to 57.6% on September 28, 2026.
The optical networking specialist gained as the screener flagged the high growth projection, and the market confirmed with strong volume. No company-specific earnings news emerged, but the move aligns with robust demand for cloud and AI infrastructure. The upward estimate revision signals confidence in Lumentum's margin expansion and revenue visibility.
LITE EPS revision history → · Screener snapshot from 2026-09-28 →
FAQ: LITE
Why did LITE stock jump?
LITE jumped 17.8% to $1,085.42 after analysts revised its next-year EPS growth estimate to 57.6% on September 28, 2026.
What caused Lumentum's surge?
Lumentum's surge was driven by a 57.6% next-year EPS growth revision, reflecting strong demand for optical components in AI and cloud data centers.
What is LITE's EPS growth estimate?
Lumentum's next-year EPS growth estimate is 57.6%, one of the highest among technology hardware companies.
Why did COHR stock jump in October 2026?
Coherent Corp (COHR) gained 17.1% from $287.81 to $337.04 after its next-year EPS growth estimate was revised to 49.9% on September 30, 2026.
The photonics and laser maker benefited from the screener's early signal, which preceded a broad rally in semiconductor and optical stocks. No earnings-related news was reported, but the revision highlights improving profitability tied to industrial and telecom demand. The price action suggests investors are rewarding companies with visible earnings acceleration.
COHR EPS revision history → · Screener snapshot from 2026-09-30 →
FAQ: COHR
Why did COHR stock jump?
COHR jumped 17.1% to $337.04 after its next-year EPS growth estimate was revised to 49.9% on September 30, 2026.
Is COHR a buy after the rally?
A 49.9% EPS growth estimate supports a positive outlook, but the 17% gain in three days warrants caution; watch for sustainable demand in photonics.
What is COHR's EPS growth estimate?
Coherent's next-year EPS growth estimate is 49.9%, indicating strong expected earnings expansion.
Why did CAMT stock jump in October 2026?
Camtek Ltd (CAMT) advanced 15.8% from $142.61 to $165.19 after its next-year EPS growth estimate was revised to 35.6% on September 28, 2026.
The Israeli inspection-equipment maker gained as the screener identified the upward revision, and the stock benefited from a sector-wide semiconductor equipment rally. No specific news was reported, but the move reflects growing demand for advanced packaging and inspection tools. The earnings growth estimate suggests analysts see continued momentum in Camtek's niche.
CAMT EPS revision history → · Screener snapshot from 2026-09-28 →
FAQ: CAMT
Why did CAMT stock jump?
CAMT jumped 15.8% to $165.19 after its next-year EPS growth estimate was revised to 35.6% on September 28, 2026.
What caused Camtek's surge?
Camtek's surge followed a 35.6% next-year EPS growth revision, driven by strong demand for its inspection equipment used in advanced chip packaging.
What is CAMT's EPS growth estimate?
Camtek's next-year EPS growth estimate is 35.6%, reflecting expected earnings acceleration in the semiconductor equipment sector.
Today's top performers—led by Immutep's explosive 1573% gain—signal that investors are aggressively rotating into small-cap biotech and tech hardware names with strong forward earnings revisions. The synchronized rallies in Lumentum, Coherent, Camtek, and Pyxis Tankers suggest broad optimism around AI infrastructure and energy shipping, though the extreme moves may invite volatility.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →